- This topic is empty.
-
Posts
-
-
This page contains summary of CNBC program “Mad Money w/ Jim Cramer” which was on air on Monday, January 13, 2025. It also contains links to CNBC sites which contain video clips and transcripts.
(1) Jim Cramer explains why the Nasdaq failed to rally on Monday (https://www.cnbc.com/2025/01/13/jim-cramer-explains-why-the-nasdaq-failed-to-rally-on-monday.html)
- CNBC’s Jim Cramer examined Monday’s market action, saying the tech-heavy Nasdaq failed to rally largely due to a unique one-two punch: The U.S. government and billionaire Meta CEO Mark Zuckerberg.
- The Biden administration announced new restrictions on semiconductor exports, and Zuckerberg panned Apple in an interview with Joe Rogan.
- “The tag team of the government and Meta may have been too much for everyone,” he said. “At the end of the day, though, buyers finally came in to find bargains in the semis and softwares and the drug stocks.”
(2) Executive Interview: Bristol Myers Squibb CEO describes new drug for treating schizophrenia (https://www.cnbc.com/2025/01/13/bristol-myers-squibb-ceo-describes-new-drug-for-treating-schizophrenia-.html)
- Bristol Myers Squibb CEO Chris Boerner described his company’s new drug, Cobenfy, which can be used to treat psychiatric disorders like schizophrenia.
- He said the treatment is effective but doesn’t carry the serious side effects of other traditional medications.
- The Food and Drug administration approved Cobenfy in September of 2024, and it is the first new type of treatment for the disorder in decades.
Ticker: BMY
(3) [No Video Clip for non-Club members] Executive Interview: Medtronic CEO Geoff Martha sits down with Jim Cramer (https://www.cnbc.com/video/2025/01/13/medtronic-ceo-geoff-martha-sits-down-with-jim-cramer.html)
Medtronic CEO Geoff Martha joins ‘Mad Money’ host Jim Cramer at the JPMorgan Healthcare Conference to talk its Parkinson’s treatment, partnering with SpaceX, products in the pipeline, and more.
Ticker: MDT
(4) [No Video Clip for non-Club members] Executive Interview: We have the largest venture portfolio in medtech, says Boston Scientific CEO Mike Mahoney (https://www.cnbc.com/video/2025/01/13/we-have-the-largest-venture-portfolio-in-medtech-says-boston-scientific-ceo-mike-mahoney.html)
Boston Scientific Chair and CEO Mike Mahoney joins ‘Mad Money’ host Jim Cramer at the JPMorgan Healthcare Conference to talk its outlook for 2025, its venture portfolio, and more.
Ticker: BSX
(5) Cramer’s Lightning Round: Arbutus Biopharma is ‘the ultimate spec’ (https://www.cnbc.com/2025/01/13/cramers-lightning-round-arbutus-biopharma-is-the-ultimate-spec.html)
- Kraft Heinz: “That’s the worst collection of brands I’ve ever seen. I think those guys should continue to go lower.”
- Ralph Lauren: “They’ve got tremendous design…You’ve got a winner there.”
- Aspen Aerogels: “I would be very slow in buying that stock.”
- KKR: “I like the stock very much…I would be a buyer.”
- Crown Castle: “I have not liked Crown Castle for ages.”
Ticker: KHC, RL, ASPN, ABUS, ALK, KKR, CCI
(6) [No Video Clip for non-Club members] Jim Cramer on the gamification of quantum computing stocks (https://www.cnbc.com/video/2025/01/13/jim-cramer-on-the-gamification-of-quantum-computing-stocks.html)
‘Mad Money’ host Jim Cramer takes a closer look at the quantum computing space.
Other Stocks Discussed (calls with audience): AMD (AMD) [hold], Builders FIrstSource (BLDR)
Ref: Links to other sites that relate to episode of January 13, 2025
- Podcast at Spotify (Sound from Spotify）
- Internet Archive （Video & Texts per minute）
****************************
Previous episode Next Episode
-
- The topic ‘Mad Money: Key points from January 13, 2025 (Monday) Episode’ is closed to new replies.